Robert J. O'Shea, 10% Owner at PDL BIOPHARMA, INC. (PDLI), bought 2,090,000 shares at $2.45 ($5.4M) on 2020-12-11, disclosed to the SEC on 2020-12-15.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.45 | 450,000 | $1.1M | 20.5% |
| 2 | $2.62 | 640,000 | $1.7M | 31.2% |
| 3 | $2.59 | 1,000,000 | $2.6M | 48.2% |
| Total | $2.57 avg | 2,090,000 | $5.4M | 100% |
| Ticker | Type | Filed | Value | 7d Stock | Filing |
|---|---|---|---|---|---|
| PrivateKeenova Therapeutics plc | BUY | 2025-12-10 | $23.2M | — | Filing → |
| PrivateCopper Property CTL Pass Through Trust | BUY |
| 2025-10-23 |
| $10.7M |
| — |
| Filing → |
| PrivateCopper Property CTL Pass Through Trust | BUY | 2025-10-21 | $3.8M | — | Filing → |
| PrivateCopper Property CTL Pass Through Trust | BUY | 2025-08-06 | $889K | — | Filing → |
| GPOR | SELL | 2024-11-25 | $166.1M | — | Filing → |